Urinary tract infections are common and unpleasant, but a research team at Vanderbilt University has developed a ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

UTIs are among the most common infections worldwide, affecting some 15 million women a year. Phenazopyridine, sold under brand names such as Azo and Uristat, is used to treat the pain, burning and ...

NSAIDs, which include ibuprofen (Advil, Motrin), naproxen (Aleve) and aspirin (Bayer), help relieve pain by rushing to sites ...

If you've been using Zyrtec or Xyzal to combat your allergy symptoms this year, an FDA warning wants you to be aware of this ...

Here’s how it works. The best Android tablets are better than ever, and as we've seen over years of testing the latest slates, they can power through apps and games without breaking a sweat and ...

The generic drug, montelukast should be offered ... NICE said earlier use of the 7 pence per day tablet could save the NHS £3 million per year for every 10,000 people who take up the new ...

The regulator has set a timeframe of 12th August for its review of the new drug application (NDA) and – if approved – brensocatib could become a much-needed treatment option for hundreds of ...

The Center for Biosimilars connects professionals with insights on biosimilars, health economics, regulatory outcomes, and ...